BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 36030965)

  • 1. Characterization of arrhythmia substrate to ablate persistent atrial fibrillation (COAST-AF): Randomized controlled trial design and rationale.
    Nery PB; Wells GA; Verma A; Joza J; Nair GM; Veenhuyzen G; Andrade J; Nault I; Wong JA; Sikkel M; Essebag V; Macle L; Sapp J; Roux JF; Skanes A; Angaran P; Novak P; Redfearn D; Golian M; Redpath CJ; Sturmer M; Birnie D
    Am Heart J; 2022 Dec; 254():133-140. PubMed ID: 36030965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Catheter Ablation Using Pulmonary Vein Isolation With vs Without Posterior Left Atrial Wall Isolation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial Fibrillation: The CAPLA Randomized Clinical Trial.
    Kistler PM; Chieng D; Sugumar H; Ling LH; Segan L; Azzopardi S; Al-Kaisey A; Parameswaran R; Anderson RD; Hawson J; Prabhu S; Voskoboinik A; Wong G; Morton JB; Pathik B; McLellan AJ; Lee G; Wong M; Finch S; Pathak RK; Raja DC; Sterns L; Ginks M; Reid CM; Sanders P; Kalman JM
    JAMA; 2023 Jan; 329(2):127-135. PubMed ID: 36625809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy and safety of left atrial low-voltage area guided ablation for recurrence prevention compared to pulmonary vein isolation alone in patients with persistent atrial fibrillation trial: Design and rationale.
    Sunaga A; Masuda M; Inoue K; Tanaka N; Watanabe T; Furukawa Y; Egami Y; Hirata A; Makino N; Minamiguchi H; Oka T; Minamisaka T; Takeda T; Yamada T; Kitamura T; Kida H; Oeun B; Sato T; Sotomi Y; Dohi T; Okada K; Suna S; Mizuno H; Nakatani D; Hikoso S; Sakata Y;
    Clin Cardiol; 2021 Sep; 44(9):1249-1255. PubMed ID: 34291484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Posterior Left Atrial Voltage on Ablation Outcomes in Persistent Atrial Fibrillation: CAPLA Substudy.
    Chieng D; Sugumar H; Hunt A; Ling LH; Segan L; Al-Kaisey A; Hawson J; Prabhu S; Voskoboinik A; Wong G; Morton JB; Lee G; Ginks M; Sterns L; Sanders P; Kalman JM; Kistler PM
    JACC Clin Electrophysiol; 2023 Nov; 9(11):2291-2299. PubMed ID: 37715741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catheter Ablation of Low-Voltage Areas for Persistent Atrial Fibrillation: Procedural Outcomes Using High-Density Voltage Mapping.
    Nery PB; Alqarawi W; Nair GM; Sadek MM; Redpath CJ; Golian M; Al Dawood W; Chen L; Hansom SP; Klein A; Wells GA; Birnie DH
    Can J Cardiol; 2020 Dec; 36(12):1956-1964. PubMed ID: 32738208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ablation of Persistent Atrial Fibrillation Targeting Low-Voltage Areas With Selective Activation Characteristics.
    Jadidi AS; Lehrmann H; Keyl C; Sorrel J; Markstein V; Minners J; Park CI; Denis A; Jaïs P; Hocini M; Potocnik C; Allgeier J; Hochholzer W; Herrera-Siklody C; Kim S; Omri YE; Neumann FJ; Weber R; Haïssaguerre M; Arentz T
    Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):. PubMed ID: 26966286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of MRI-Guided Fibrosis Ablation vs Conventional Catheter Ablation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial Fibrillation: The DECAAF II Randomized Clinical Trial.
    Marrouche NF; Wazni O; McGann C; Greene T; Dean JM; Dagher L; Kholmovski E; Mansour M; Marchlinski F; Wilber D; Hindricks G; Mahnkopf C; Wells D; Jais P; Sanders P; Brachmann J; Bax JJ; Morrison-de Boer L; Deneke T; Calkins H; Sohns C; Akoum N;
    JAMA; 2022 Jun; 327(23):2296-2305. PubMed ID: 35727277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stand-Alone Pulmonary Vein Isolation Versus Pulmonary Vein Isolation With Additional Substrate Modification as Index Ablation Procedures in Patients With Persistent and Long-Standing Persistent Atrial Fibrillation: The Randomized Alster-Lost-AF Trial (Ablation at St. Georg Hospital for Long-Standing Persistent Atrial Fibrillation).
    Fink T; Schlüter M; Heeger CH; Lemes C; Maurer T; Reissmann B; Riedl J; Rottner L; Santoro F; Schmidt B; Wohlmuth P; Mathew S; Sohns C; Ouyang F; Metzner A; Kuck KH
    Circ Arrhythm Electrophysiol; 2017 Jul; 10(7):. PubMed ID: 28687670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stepwise ablation approach versus pulmonary vein isolation in patients with paroxysmal atrial fibrillation: Randomized controlled trial.
    Faustino M; Pizzi C; Agricola T; Xhyheri B; Costa GM; Flacco ME; Capasso L; Cicolini G; Di Girolamo E; Leonzio L; Manzoli L
    Heart Rhythm; 2015 Sep; 12(9):1907-15. PubMed ID: 26051530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy outcomes of left atrial posterior wall isolation compared to pulmonary vein isolation and pulmonary vein isolation with linear ablation for the treatment of persistent atrial fibrillation.
    Sutter JS; Lokhnygina Y; Daubert JP; Bahnson T; Jackson K; Koontz JI; Sun AY; Hegland DD; Thomas KL; Jackson L; Lewis R; Granger C; Piccini JP; Atwater BD
    Am Heart J; 2020 Feb; 220():89-96. PubMed ID: 31805423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex-specific outcomes after catheter ablation for persistent AF.
    Segan L; Chieng D; Crowley R; William J; Sugumar H; Ling LH; Hawson J; Prabhu S; Voskoboinik A; Morton JB; Lee G; Sterns LD; Ginks M; Sanders P; Kalman JM; Kistler PM
    Heart Rhythm; 2024 Jun; 21(6):762-770. PubMed ID: 38336190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline left atrial low-voltage area predicts recurrence after pulmonary vein isolation: WAVE-MAP AF results.
    Starek Z; Di Cori A; Betts TR; Clerici G; Gras D; Lyan E; Della Bella P; Li J; Hack B; Zitella Verbick L; Sommer P
    Europace; 2023 Aug; 25(9):. PubMed ID: 37470443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjunctive posterior wall isolation for the treatment of persistent and longstanding persistent atrial fibrillation (CORNERSTONE AF) trial: Design and rationale.
    Shigeta T; Miyazaki S; Inaba O; Inamura Y; Nitta J; Sekiguchi Y; Takahashi A; Hachiya H; Nagata Y; Yamauchi Y; Hayashi T; Iwai S; Mizukami A; Ono Y; Handa K; Suzuki M; Suzuki A; Nakajima J; Hirao K; Okada H; Negishi M; Ikenouchi T; Yamamoto T; Goto K; Nishimura T; Tao S; Takigawa M; Hirakawa A; Goya M; Sasano T
    Clin Cardiol; 2024 Jan; 47(1):e24164. PubMed ID: 37822107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Posterior Wall Isolation in Catheter Ablation for Persistent Atrial Fibrillation and Systolic Heart Failure: A Secondary Analysis of a Randomized Clinical Trial.
    William J; Chieng D; Sugumar H; Ling LH; Segan L; Crowley R; Al-Kaisey A; Hawson J; Prabhu S; Voskoboinik A; Wong G; Morton JB; Lee G; McLellan AJ; Wong M; Pathak RK; Sterns L; Ginks M; Reid CM; Sanders P; Kalman JM; Kistler PM
    JAMA Cardiol; 2023 Nov; 8(11):1077-1082. PubMed ID: 37755920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous alternative to the Maze procedure for the treatment of persistent or long-standing persistent atrial fibrillation (aMAZE trial): Rationale and design.
    Lee RJ; Lakkireddy D; Mittal S; Ellis C; Connor JT; Saville BR; Wilber D
    Am Heart J; 2015 Dec; 170(6):1184-94. PubMed ID: 26678640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Termination of persistent atrial fibrillation during pulmonary vein isolation: insight from the MAGIC-AF trial.
    Singh SM; d'Avila A; Kim YH; Aryana A; Mangrum JM; Michaud GF; Dukkipati SR; Barrett CD; Heist EK; Parides MK; Thorpe KE; Reddy VY
    Europace; 2017 Oct; 19(10):1657-1663. PubMed ID: 27702847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biatrial linear ablation in sustained nonpermanent AF: Results of the substrate modification with ablation and antiarrhythmic drugs in nonpermanent atrial fibrillation (SMAN-PAF) trial.
    Wynn GJ; Panikker S; Morgan M; Hall M; Waktare J; Markides V; Hussain W; Salukhe T; Modi S; Jarman J; Jones DG; Snowdon R; Todd D; Wong T; Gupta D
    Heart Rhythm; 2016 Feb; 13(2):399-406. PubMed ID: 26455343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Extensive Ablation on Recurrence in Patients with Persistent Atrial Fibrillation Treated with Pulmonary Vein Isolation (EARNEST-PVI) trial: Design and rationale.
    Dohi T; Nakatani D; Inoue K; Hikoso S; Oka T; Hayashi K; Masuda M; Furukawa Y; Kawasaki M; Egami Y; Kashiwase K; Hirata A; Watanabe T; Miyoshi M; Takeda T; Nakagawa A; Mizuno H; Minamiguchi H; Kitamura T; Suna S; Kojima T; Kida H; Bolrathanak O; Okuyama Y; Sakata Y;
    J Cardiol; 2019 Aug; 74(2):164-168. PubMed ID: 30853354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ganglionated plexus ablation vs linear ablation in patients undergoing pulmonary vein isolation for persistent/long-standing persistent atrial fibrillation: a randomized comparison.
    Pokushalov E; Romanov A; Katritsis DG; Artyomenko S; Shirokova N; Karaskov A; Mittal S; Steinberg JS
    Heart Rhythm; 2013 Sep; 10(9):1280-6. PubMed ID: 23608592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catheter ablation for persistent atrial fibrillation: A multicenter randomized trial of pulmonary vein isolation (PVI) versus PVI with posterior left atrial wall isolation (PWI) - The CAPLA study.
    Chieng D; Sugumar H; Ling LH; Segan L; Azzopardi S; Prabhu S; Al-Kaisey A; Voskoboinik A; Parameswaran R; Morton JB; Pathik B; McLellan AJ; Lee G; Wong M; Finch S; Pathak RK; Raja DC; Sanders P; Sterns L; Ginks M; Reid CM; Kalman JM; Kistler PM
    Am Heart J; 2022 Jan; 243():210-220. PubMed ID: 34619143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.